nateglinide Tablets 60 mg, 120 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Manufacturer #15910
This multinational pharmaceutical company focuses on a wide range of products, including prescription medications, over-the-counter drugs, APIs, and formulations. They have a strong presence in key global regions like North America, Europe, Japan, and Africa. Their expertise spans multiple therapeutic areas, particularly gastroenterology, cardiology, gynecology, diabetology, and oncology. They are known for their state-of-the-art manufacturing facilities that adhere to international standards such as USFDA, EU, MHRA UK, WHO Geneva, and TGA Australia. The company boasts a dedicated R&D team of over 350 scientists working on innovations in areas with unmet medical needs. They have achieved significant milestones by developing "world's first" innovations in lung cancer, tuberculosis, cardiovascular diseases, and gastroenterology. Their product portfolio includes a variety of dosage forms and they hold several patents for their innovative products.
None